Email This Article

Lilly Gains on Zyprexa Patent Win
By Robert Steyer
04/15/05 - 08:34 AM EDT
A judge rules generic challengers failed to prove their case.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,366.15 1,099.92 2,173.14 34.89
Oil *
78.83
DOWN
86.53
DOWN
9.32
DOWN
11.89
UP
1.09
10 Yr
3.49%
SPDR Gold
118.70
-0.83%
-0.84%
-0.54%
+3.22%
Data delayed 20 minutes

Brokerage Partners